体外毒性検査の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE3810)
◆英語タイトル:Global In-vitro Toxicity Testing Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE3810
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:108
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、体外毒性検査の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(静的ウェルプレートシステム、マルチコンパートメント灌流システム)、用途別市場規模(製薬・バイオテクノロジー企業、学術研究機関、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・体外毒性検査の市場動向
・企業の競争状況、市場シェア
・体外毒性検査の種類別市場規模(静的ウェルプレートシステム、マルチコンパートメント灌流システム)
・体外毒性検査の用途別市場規模(製薬・バイオテクノロジー企業、学術研究機関、その他)
・体外毒性検査の北米市場規模2016-2027(アメリカ、カナダ)
・体外毒性検査の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・体外毒性検査のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・体外毒性検査の中南米市場規模2016-2027(メキシコ、ブラジル)
・体外毒性検査の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Abbott Laboratories、Agilent Technologies Inc.、Bio-Rad Laboratories Inc.、CELTHER POLSKA Sp z o.o.、Charles River Laboratories International Inc.、Eurofins GSC Lux Sarl、Evotec AG、General Electric Co.、Merck KGaA、Thermo Fisher Scientific Inc.)
・結論
【レポートの概要】

In-vitro and in-silico testing methods are being preferred over in-vivo testing methods in the pharmaceutical industry because of the growing need to detect diseases at the molecular level and identify biological functionalities with minimal adverse effects.
The development of advanced technologies, such as 3D cell culture technologies, cellular imaging technologies, and toxicogenomics has further supported the adoption of in-vitro testing methods. These technologies help in replicating in-vivo systems and thereby eliminate the need to experiment on human or animal models.

Market Analysis and Insights: Global In-vitro Toxicity Testing Market
The global In-vitro Toxicity Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global In-vitro Toxicity Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global In-vitro Toxicity Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global In-vitro Toxicity Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global In-vitro Toxicity Testing market.

Global In-vitro Toxicity Testing Scope and Market Size
In-vitro Toxicity Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global In-vitro Toxicity Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Static Well Plate System
Multi-compartmental Perfused Systems

Segment by Application
Pharmaceutical and Biotechnology Companies
Academic and Research Institutions
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
CELTHER POLSKA Sp z o.o.
Charles River Laboratories International Inc.
Eurofins GSC Lux Sarl
Evotec AG
General Electric Co.
Merck KGaA
Thermo Fisher Scientific Inc.

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-vitro Toxicity Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Static Well Plate System
1.2.3 Multi-compartmental Perfused Systems
1.3 Market by Application
1.3.1 Global In-vitro Toxicity Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Academic and Research Institutions
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global In-vitro Toxicity Testing Market Perspective (2016-2027)
2.2 In-vitro Toxicity Testing Growth Trends by Regions
2.2.1 In-vitro Toxicity Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 In-vitro Toxicity Testing Historic Market Share by Regions (2016-2021)
2.2.3 In-vitro Toxicity Testing Forecasted Market Size by Regions (2022-2027)
2.3 In-vitro Toxicity Testing Industry Dynamic
2.3.1 In-vitro Toxicity Testing Market Trends
2.3.2 In-vitro Toxicity Testing Market Drivers
2.3.3 In-vitro Toxicity Testing Market Challenges
2.3.4 In-vitro Toxicity Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top In-vitro Toxicity Testing Players by Revenue
3.1.1 Global Top In-vitro Toxicity Testing Players by Revenue (2016-2021)
3.1.2 Global In-vitro Toxicity Testing Revenue Market Share by Players (2016-2021)
3.2 Global In-vitro Toxicity Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by In-vitro Toxicity Testing Revenue
3.4 Global In-vitro Toxicity Testing Market Concentration Ratio
3.4.1 Global In-vitro Toxicity Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-vitro Toxicity Testing Revenue in 2020
3.5 In-vitro Toxicity Testing Key Players Head office and Area Served
3.6 Key Players In-vitro Toxicity Testing Product Solution and Service
3.7 Date of Enter into In-vitro Toxicity Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 In-vitro Toxicity Testing Breakdown Data by Type
4.1 Global In-vitro Toxicity Testing Historic Market Size by Type (2016-2021)
4.2 Global In-vitro Toxicity Testing Forecasted Market Size by Type (2022-2027)

5 In-vitro Toxicity Testing Breakdown Data by Application
5.1 Global In-vitro Toxicity Testing Historic Market Size by Application (2016-2021)
5.2 Global In-vitro Toxicity Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America In-vitro Toxicity Testing Market Size (2016-2027)
6.2 North America In-vitro Toxicity Testing Market Size by Type
6.2.1 North America In-vitro Toxicity Testing Market Size by Type (2016-2021)
6.2.2 North America In-vitro Toxicity Testing Market Size by Type (2022-2027)
6.2.3 North America In-vitro Toxicity Testing Market Size by Type (2016-2027)
6.3 North America In-vitro Toxicity Testing Market Size by Application
6.3.1 North America In-vitro Toxicity Testing Market Size by Application (2016-2021)
6.3.2 North America In-vitro Toxicity Testing Market Size by Application (2022-2027)
6.3.3 North America In-vitro Toxicity Testing Market Size by Application (2016-2027)
6.4 North America In-vitro Toxicity Testing Market Size by Country
6.4.1 North America In-vitro Toxicity Testing Market Size by Country (2016-2021)
6.4.2 North America In-vitro Toxicity Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe In-vitro Toxicity Testing Market Size (2016-2027)
7.2 Europe In-vitro Toxicity Testing Market Size by Type
7.2.1 Europe In-vitro Toxicity Testing Market Size by Type (2016-2021)
7.2.2 Europe In-vitro Toxicity Testing Market Size by Type (2022-2027)
7.2.3 Europe In-vitro Toxicity Testing Market Size by Type (2016-2027)
7.3 Europe In-vitro Toxicity Testing Market Size by Application
7.3.1 Europe In-vitro Toxicity Testing Market Size by Application (2016-2021)
7.3.2 Europe In-vitro Toxicity Testing Market Size by Application (2022-2027)
7.3.3 Europe In-vitro Toxicity Testing Market Size by Application (2016-2027)
7.4 Europe In-vitro Toxicity Testing Market Size by Country
7.4.1 Europe In-vitro Toxicity Testing Market Size by Country (2016-2021)
7.4.2 Europe In-vitro Toxicity Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific In-vitro Toxicity Testing Market Size (2016-2027)
8.2 Asia-Pacific In-vitro Toxicity Testing Market Size by Type
8.2.1 Asia-Pacific In-vitro Toxicity Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific In-vitro Toxicity Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific In-vitro Toxicity Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific In-vitro Toxicity Testing Market Size by Application
8.3.1 Asia-Pacific In-vitro Toxicity Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific In-vitro Toxicity Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific In-vitro Toxicity Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific In-vitro Toxicity Testing Market Size by Region
8.4.1 Asia-Pacific In-vitro Toxicity Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific In-vitro Toxicity Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America In-vitro Toxicity Testing Market Size (2016-2027)
9.2 Latin America In-vitro Toxicity Testing Market Size by Type
9.2.1 Latin America In-vitro Toxicity Testing Market Size by Type (2016-2021)
9.2.2 Latin America In-vitro Toxicity Testing Market Size by Type (2022-2027)
9.2.3 Latin America In-vitro Toxicity Testing Market Size by Type (2016-2027)
9.3 Latin America In-vitro Toxicity Testing Market Size by Application
9.3.1 Latin America In-vitro Toxicity Testing Market Size by Application (2016-2021)
9.3.2 Latin America In-vitro Toxicity Testing Market Size by Application (2022-2027)
9.3.3 Latin America In-vitro Toxicity Testing Market Size by Application (2016-2027)
9.4 Latin America In-vitro Toxicity Testing Market Size by Country
9.4.1 Latin America In-vitro Toxicity Testing Market Size by Country (2016-2021)
9.4.2 Latin America In-vitro Toxicity Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa In-vitro Toxicity Testing Market Size (2016-2027)
10.2 Middle East & Africa In-vitro Toxicity Testing Market Size by Type
10.2.1 Middle East & Africa In-vitro Toxicity Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa In-vitro Toxicity Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa In-vitro Toxicity Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa In-vitro Toxicity Testing Market Size by Application
10.3.1 Middle East & Africa In-vitro Toxicity Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa In-vitro Toxicity Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa In-vitro Toxicity Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa In-vitro Toxicity Testing Market Size by Country
10.4.1 Middle East & Africa In-vitro Toxicity Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa In-vitro Toxicity Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories In-vitro Toxicity Testing Introduction
11.1.4 Abbott Laboratories Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent Technologies Inc.
11.2.1 Agilent Technologies Inc. Company Details
11.2.2 Agilent Technologies Inc. Business Overview
11.2.3 Agilent Technologies Inc. In-vitro Toxicity Testing Introduction
11.2.4 Agilent Technologies Inc. Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.2.5 Agilent Technologies Inc. Recent Development
11.3 Bio-Rad Laboratories Inc.
11.3.1 Bio-Rad Laboratories Inc. Company Details
11.3.2 Bio-Rad Laboratories Inc. Business Overview
11.3.3 Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Introduction
11.3.4 Bio-Rad Laboratories Inc. Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.3.5 Bio-Rad Laboratories Inc. Recent Development
11.4 CELTHER POLSKA Sp z o.o.
11.4.1 CELTHER POLSKA Sp z o.o. Company Details
11.4.2 CELTHER POLSKA Sp z o.o. Business Overview
11.4.3 CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Introduction
11.4.4 CELTHER POLSKA Sp z o.o. Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.4.5 CELTHER POLSKA Sp z o.o. Recent Development
11.5 Charles River Laboratories International Inc.
11.5.1 Charles River Laboratories International Inc. Company Details
11.5.2 Charles River Laboratories International Inc. Business Overview
11.5.3 Charles River Laboratories International Inc. In-vitro Toxicity Testing Introduction
11.5.4 Charles River Laboratories International Inc. Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.5.5 Charles River Laboratories International Inc. Recent Development
11.6 Eurofins GSC Lux Sarl
11.6.1 Eurofins GSC Lux Sarl Company Details
11.6.2 Eurofins GSC Lux Sarl Business Overview
11.6.3 Eurofins GSC Lux Sarl In-vitro Toxicity Testing Introduction
11.6.4 Eurofins GSC Lux Sarl Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.6.5 Eurofins GSC Lux Sarl Recent Development
11.7 Evotec AG
11.7.1 Evotec AG Company Details
11.7.2 Evotec AG Business Overview
11.7.3 Evotec AG In-vitro Toxicity Testing Introduction
11.7.4 Evotec AG Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.7.5 Evotec AG Recent Development
11.8 General Electric Co.
11.8.1 General Electric Co. Company Details
11.8.2 General Electric Co. Business Overview
11.8.3 General Electric Co. In-vitro Toxicity Testing Introduction
11.8.4 General Electric Co. Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.8.5 General Electric Co. Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Details
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA In-vitro Toxicity Testing Introduction
11.9.4 Merck KGaA Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.9.5 Merck KGaA Recent Development
11.10 Thermo Fisher Scientific Inc.
11.10.1 Thermo Fisher Scientific Inc. Company Details
11.10.2 Thermo Fisher Scientific Inc. Business Overview
11.10.3 Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Introduction
11.10.4 Thermo Fisher Scientific Inc. Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.10.5 Thermo Fisher Scientific Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 体外毒性検査の世界市場規模・現状・予測2021年-2027年(Global In-vitro Toxicity Testing Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。